The long goal of this proposal is to understand the roles of the naturally occurring polycations, the polyamines, in normal and neoplastic cell proliferation and in cellular responses to stress. A major hypothesis to be tested in the proposed work is that multiple metabolic pathways are coordinately regulated in mammalian cells, and that one coordinately regulated pathway includes enzymes involved in polyamine biosynthesis, such as ornithine decarboxylase, certain stress-induced proteins, such as the Mr=70,000 heat shock protein, and specific growth-associated proteins, including p53 and those encoded by the oncogenes c-myc, c-fos and v-myb. Since it is known that the polyamines putrescine and spermidine can regulate aspects of ornithine decarboxylase expression in a post-transcriptional manner, the proposed work will, first, explore specific mechanisms of this polyamine-dependent post-transcriptional regulation of ornithine decarboxylase and, second, determine whether the expression of other proteins sharing common features, such as long 5' untranslated leader sequences in their encoding mRNAs and common amino acid sequences which appear to characterize their rapid degradation rates, is also regulated in a polyamine-dependent fashion. This work will utilize cell-free synthesis of appropriately modified mRNAs, coupled with translation in polyamine-depleted reticulocyte lysates, to document effects of polyamines on mRNA translation. Modified cDNAs will be transfected into cells to investigate specific aspects of protein degradation. A final specific aim will investigate the mechanism of elevated ornithine decarboxylase activity in certain premalignant tissues, such as those from humans with Barrett's esophagus. These latter studies will ask whether the elevated enzyme activity is to a post-transcriptional process affecting either translation mRNA or the stability of the protein. The results of these studies will impact our understanding of the regulation of mammalian normal and tumor cell growth, and contribute to our knowledge of how cells respond to certain toxic stresses, such as those used in certain forms of cancer treatment. The findings of this work should be of interest to a variety of cancer researchers and could find applications in both the chemoprevention or therapy of human cancers.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA047396-05
Application #
3191024
Study Section
Biochemistry Study Section (BIO)
Project Start
1988-09-30
Project End
1994-07-31
Budget Start
1992-08-01
Budget End
1994-07-31
Support Year
5
Fiscal Year
1992
Total Cost
Indirect Cost
Name
University of Arizona
Department
Type
Schools of Medicine
DUNS #
City
Tucson
State
AZ
Country
United States
Zip Code
85721
Raj, K P; Zell, J A; Rock, C L et al. (2013) Role of dietary polyamines in a phase III clinical trial of difluoromethylornithine (DFMO) and sulindac for prevention of sporadic colorectal adenomas. Br J Cancer 108:512-8
Rial, Nathaniel S; Zell, Jason A; Cohen, Alfred M et al. (2012) Clinical end points for developing pharmaceuticals to manage patients with a sporadic or genetic risk of colorectal cancer. Expert Rev Gastroenterol Hepatol 6:507-17
Laukaitis, Christina M; Gerner, Eugene W (2011) DFMO: targeted risk reduction therapy for colorectal neoplasia. Best Pract Res Clin Gastroenterol 25:495-506
Gerner, Eugene W; Meyskens Jr, Frank L (2009) Combination chemoprevention for colon cancer targeting polyamine synthesis and inflammation. Clin Cancer Res 15:758-61
Zell, Jason A; Pelot, Daniel; Chen, Wen-Pin et al. (2009) Risk of cardiovascular events in a randomized placebo-controlled, double-blind trial of difluoromethylornithine plus sulindac for the prevention of sporadic colorectal adenomas. Cancer Prev Res (Phila) 2:209-12
Meyskens Jr, Frank L; McLaren, Christine E; Pelot, Daniel et al. (2008) Difluoromethylornithine plus sulindac for the prevention of sporadic colorectal adenomas: a randomized placebo-controlled, double-blind trial. Cancer Prev Res (Phila) 1:32-8
Wallon, U M; Shassetz, L R; Cress, A E et al. (1994) Polyamine-dependent expression of the matrix metalloproteinase matrilysin in a human colon cancer-derived cell line. Mol Carcinog 11:138-44
Tome, M E; Fiser, S M; Gerner, E W (1994) Consequences of aberrant ornithine decarboxylase regulation in rat hepatoma cells. J Cell Physiol 158:237-44
Hixson, L J; Emerson, S S; Shassetz, L R et al. (1994) Sources of variability in estimating ornithine decarboxylase activity and polyamine contents in human colorectal mucosa. Cancer Epidemiol Biomarkers Prev 3:317-23
Gerrish, K E; Fuller, D J; Gerner, E W et al. (1993) Inhibition of DFMO-induced audiogenic seizures by chlordiazepoxide. Life Sci 52:1101-8

Showing the most recent 10 out of 15 publications